Gene therapy reduces cholesterol by 52% for 6 months with single injection
This week brought major advances in gene editing—from treating inherited diseases to understanding how cells work. Here's what caught our attention.
🧬 Single gene therapy injection cuts cholesterol in half
6 patients with familial hypercholesterolemia got a single IV dose of YOLT-101, a gene therapy that uses base editing to permanently disable the PCSK9 gene
At the highest dose (0.6 mg/kg), patients saw their LDL cholesterol drop by 52.3% and PCSK9 protein levels fall by 74.4%—and these reductions lasted the full 24 weeks of follow-up
No serious side effects occurred, just temporary infusion reactions and mild liver enzyme elevations that resolved on their own
Why it matters: This could be a one-time treatment for people with genetic high cholesterol who can't control it with current medications. The base editing approach permanently rewrites DNA without the large deletions that other gene editing tools sometimes cause.
Key Findings
🎯 New tool maps gene regulation at single-letter precision
Researchers developed a method to identify exactly which DNA letters control gene expression by reading the actual genetic changes at target sites, rather than inferring them indirectly
Testing this on the CD19 gene (a target for leukemia immunotherapy), they pinpointed specific transcription factor binding sites that are crucial for the gene's activity
When they mutated the MYB and PAX5 binding sites, cancer cells became resistant to CAR-T cell therapy—revealing how genetic variants could help tumors escape treatment
🔬 Base editing avoids dangerous DNA deletions in cholesterol gene
Scientists used cytosine base editing to introduce stop signals into the LPA gene (which makes lipoprotein(a), a heart disease risk factor) in mice
This approach produced sustained reductions in circulating apolipoprotein(a) while causing large DNA deletions in less than 4% of cases
In contrast, traditional CRISPR/Cas9 cutting resulted primarily in large deletions, which could be harmful
🧪 CRISPR kill switch leaves genetic traces behind
Engineered E. coli bacteria designed with a CRISPR kill switch to prevent environmental spread showed escape rates of 10^-1.6 to 10^-1 when measured by DNA detection, despite colony growth rates of only 10^-6.2
The target genes remained detectable and protected inside intact cell membranes for hours after biocontainment activation, though they degraded over days in river water
This means genetic material from biocontained organisms could persist in the environment longer than expected
🩺 Portable CRISPR test detects multiple STIs in one assay
A multiplexed CRISPR diagnostic detected gonorrhea with 80% sensitivity, chlamydia with 73% sensitivity, syphilis with 82.5% sensitivity, and herpes with 94.4% sensitivity in 900 clinical samples
The test also identified a specific antibiotic resistance mutation (gyrA S91F) in gonorrhea with 63.1% overall sensitivity, reaching 85.7% in genital samples
Each pathogen was detected using two independent DNA regions and different fluorescent signals, with results available at the point of care
🔬 Mapping 80,000+ mutations reveals essential protein interaction sites
Scientists used base editing to mutate 7,293 short linear motifs (protein binding sites) with 80,473 different mutations across the human genome in HAP1 cells
They identified 450 known and 264 predicted motifs that are required for normal cell growth, including many that don't belong to existing categories
The results were highly reproducible in a second cell line (RPE1), with differences mainly due to cell-type-specific gene requirements
🧬 Natural CRISPR system controls gene expression without cutting DNA
Researchers discovered that some bacteria use dead Cas12f proteins (that can't cut DNA) paired with specialized sigma factors to turn genes on in response to guide RNAs
This natural system can activate transcription without requiring traditional promoter sequences, with transcription starting at sites defined solely by the distance from the Cas12f binding location
The discovery reveals that bacteria evolved their own version of CRISPR activation technology millions of years before scientists invented it
Implications
Gene editing is rapidly moving from experimental tool to practical medicine, with new therapies showing sustained effects and safer approaches emerging. Meanwhile, discoveries of natural CRISPR systems and precise mapping techniques are expanding our understanding of how genes are controlled—setting the stage for even more targeted treatments.
Studies in this issue
Primary sources used for this newsletter.
- Gene editing treatment for inherited high cholesterol: early human trialmain storyNature medicine2026-03-03PMID 41776075
- CRISPR-based tests for quick detection of sexually transmitted infections at the point of carekey findingThe Lancet. Microbe2026-03-06PMID 41791397
- Precise DNA editing of LPA gene in modified mice prevents large DNA losseskey findingMolecular therapy : the journal of the American Society of Gene Therapy2026-03-05PMID 41782368
- Genetic markers can still be found in engineered microbes controlled by a CRISPR kill switchkey findingEnvironmental science & technology2026-03-02PMID 41766140
- Small CRISPR-Cas12f proteins guide RNA to control gene activitykey findingNature2026-03-04PMID 41781627
- A comprehensive map showing how protein interaction sites depend on each other across all proteinskey findingNature structural & molecular biology2026-03-06PMID 41792279
- Mapping gene control regions at single DNA letter resolution using targeted DNA editingkey findingNature communications2026-03-02PMID 41771871
Continue reading
All CRISPR Gene Editing issuesGet the next CRISPR Gene Editing issue
Seven papers, once a week. Free.